The Bevacizumab market was valued at USD 5,561.07 Million in 2022 and is expected to reach USD 8,560.41 Million by 2030, growing at a CAGR of 9.79% (2023-2030). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.